We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBOC:NASDAQInternational Bancshares Corporation Analysis

Data as of 2026-06-09 - not real-time

$74.48

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

International Bancshares (IBOC) is trading at $74.48, comfortably above its 20‑day SMA ($72.24) and 50‑day SMA ($71.51), indicating a sustained bullish bias. The RSI sits at 61.8, well below overbought levels, while the MACD line remains above its signal, reinforcing momentum. Valuation metrics are compelling: the trailing P/E of 11.1 is markedly lower than the industry average of 16.6, and the DCF‑derived fair value of $84.9 suggests roughly a 17% upside potential. The dividend yield of 1.95% coupled with a modest payout ratio of 21% underscores dividend sustainability. Risk indicators are moderate, with a beta of 0.71 and 30‑day volatility of 18.5%, and volume trends are increasing, supporting liquidity. A recent insider transaction saw a director sell $720,000 worth of shares, a localized event that is unlikely to shift the broader upside narrative.
Overall, IBOC blends solid fundamentals, attractive valuation, and supportive technicals, positioning it as a potentially rewarding play for investors seeking stable income and capital appreciation in the regional banking sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (price above SMAs, MACD bullish)
  • Support level at $70.28 provides downside cushion
  • Director sale is isolated and not material to market cap

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF fair value and industry P/E
  • Strong cash position versus debt and low payout ratio
  • Consistent dividend yield enhancing total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable regional footprint in Texas and Oklahoma
  • Sustainable earnings growth and solid ROE (~13.5%)
  • Low beta and moderate volatility suggest defensive characteristics

Key Metrics & Analysis

Financial Health

Revenue Growth5.40%
Profit Margin49.85%
P/E Ratio11.1
ROE13.51%
ROA2.52%
P/B Ratio1.4
Op. Cash Flow$471.3M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI61.8
Support$70.28
Resistance$75.68
MA 20$72.24
MA 50$71.51
MA 200$69.54
MACDBullish
VolumeIncreasing
Fear & Greed Index85.95

Valuation

Fair Value$84.91
Target Price$87.00
Upside/Downside16.81%
GradeUndervalued
TypeValue
Dividend Yield1.95%

Risk Assessment

Beta0.71
Volatility18.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.